Department of Head and Neck Surgery, Sichuan Cancer Hospital, Sichuan Cancer Institute, Sichuan Cancer Prevention and Treatment Center, Cancer Hospital of University of Electronic Science and Technology School of Medicine, No. 55 Section4, Renming South Road, Chengdu, China.
Updates Surg. 2024 Aug;76(4):1413-1423. doi: 10.1007/s13304-024-01760-3. Epub 2024 Mar 26.
The surgical resection range of papillary thyroid microcarcinoma of the isthmus (PTMCI) is controversial, and the guidelines do not fully guide the central lymph node dissection (CLND).We retrospectively studied the comparison of PTMCI (Group A, n = 65 cases) and non-PTMCI (Group B, n = 80 cases). Based on whether central lymph node metastasis (CLNM) was further detected, they were further divided into the PTMCI with CLNM (group C, n = 42 cases), the PTMCI without CLNM (group D, n = 23 cases), the non-PTMCI with CLNM (group E, n = 45 cases), the non-PTMCI without CLNM (group F, n = 35 cases). All patients underwent total thyroidectomy and CLND. The CLNM pathological examination was divided into right recurrent laryngeal nerve superficial lymph nodes (Right VI a), right recurrent laryngeal nerve deep lymph nodes (Right VI b), left VI area lymph nodes (Left VI), prelaryngeal lymph node, and pretracheal lymph node. The extent of lymph node metastasis and risk factors of PTMCI were analyzed by univariate and multivariate analysis. The ROC curve was used to calculate the maximum diameter of the tumor and the Youden index was calculated to analyze the impact of diameter on the risk factors for CLNM in PTMCI. To construct a prediction model of transfer risk of high risk factors by Nomogram, there were significant differences in prelaryngeal lymph nodes (p = 0.034) and pretracheal lymph nodes ( n = 0.035) between group A and group B, and the risk factors of lymph node metastasis were tumor invasion (p = 0.003), multifocality (p = 0.001), and the maximum tumor diameter≧6.5 mm. PTMCI is more prone to metastasis of pretracheal lymph nodes and prelaryngeal lymph nodes, and the presence of tumor invasion, multifocality, and tumor diameter≧6.5 mm are high risk factors for metastasis in PTMCI. According to the prediction model, with all risk factors the risk of cervical lymph node metastasis is up to 90%.
甲状腺峡部微小乳头状癌(PTMCI)的手术切除范围存在争议,指南也不能完全指导中央淋巴结清扫术(CLND)。我们回顾性研究了 PTMCI(A 组,n=65 例)与非 PTMCI(B 组,n=80 例)的比较。根据是否进一步检测到中央淋巴结转移(CLNM),将其进一步分为 PTMCI 伴 CLNM(C 组,n=42 例)、PTMCI 无 CLNM(D 组,n=23 例)、非 PTMCI 伴 CLNM(E 组,n=45 例)、非 PTMCI 无 CLNM(F 组,n=35 例)。所有患者均行甲状腺全切除术和 CLND。CLNM 病理检查分为右喉返神经浅层淋巴结(右 VI a)、右喉返神经深层淋巴结(右 VI b)、左 VI 区淋巴结(左 VI)、咽前淋巴结和气管前淋巴结。采用单因素和多因素分析分析 PTMCI 的淋巴结转移程度和危险因素。采用 ROC 曲线计算肿瘤最大直径,计算 Youden 指数分析 PTMCI 肿瘤直径对 CLNM 危险因素的影响。通过 Nomogram 构建高危因素转移风险预测模型,A 组与 B 组间在咽前淋巴结(p=0.034)和气管前淋巴结(n=0.035)方面差异有统计学意义,淋巴结转移的危险因素为肿瘤侵袭(p=0.003)、多灶性(p=0.001)和肿瘤最大直径≧6.5mm。PTMCI 更易发生气管前淋巴结和咽前淋巴结转移,肿瘤侵袭、多灶性和肿瘤直径≧6.5mm 是 PTMCI 转移的高危因素。根据预测模型,所有危险因素存在时,颈部淋巴结转移风险高达 90%。